Day: April 1, 2022

•   Fourth Quarter Total Revenue up 38% YoY to a Quarterly Record $20.8 Million •   Full Year Total Revenue Up 20% YoY to an Annual Record $62.2 Million BONITA SPRINGS, Fla., April 01, 2022 (GLOBE NEWSWIRE) — Innovative Food Holdings, Inc. (OTCQB: IVFH) (“IVFH” or the “Company”), a leading end-to-end DTC e-commerce platform and direct-to-chef platform that provides high-quality, unique specialty foods through e-commerce offerings and multichannel partnerships, today reported its financial results for the fourth quarter and full year of 2021.   “Record fourth quarter and full year revenue reflect the success of the powerful specialty food focused platforms we have created. We experienced strong 72% year-over-year foodservice revenue growth for the fourth quarter, combined with e-commerce growth of 9% for the quarter. Furthermore,...

FORT WORTH, Texas, April 01, 2022 (GLOBE NEWSWIRE) — Tandy Leather Factory, Inc. (Pink: TLFA) today announced the Company’s financial results for the fourth quarter and full year 2021. Highlights from 2021:Grew revenues 29% in 2021 to $82.7 Generated operating income of $2.3 million Net income of $1.4 million Adjusted EBITDA* of $5.4 million Ended year with $10.2 million of cash and cash equivalents Repurchased 712,690 shares at an average price of $3.84 per shareJanet Carr, Chief Executive Officer of the Company, said, “In 2021, our business continued its strong recovery from the Covid-19 crisis, with a return to profitability and sales at their highest level since 2018 despite a smaller store base. Operating expenses increased from 2020, during which our store fleet was temporarily shut down by the pandemic, but were significantly...

New York, NY, and Tel Aviv, ISRAEL, April 01, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today reported financial results for the fourth quarter and full-year ended December 31, 2021 and provided corporate updates. “2021 was a strong year for Todos Medical and we believe sets the stage for an even stronger year of growth in 2022. We have invested heavily in our newly-acquired Provista Diagnostics lab capabilities and leadership in order to be properly positioned to capture cyclical COVID testing revenue in preparation for the launch of our Videssa breast cancer blood test in early 2023,” said Gerald E. Commissiong, President & CEO of Todos Medical. “We also recently completed the acquisition of the 3CL protease assets...

Omaha, April 01, 2022 (GLOBE NEWSWIRE) — FitLife Brands Announces Preliminary 2021 Results OMAHA, NE – April 1, 2022 – FitLife Brands, Inc. (“FitLife” or the “Company”) (OTCQX: FTLF), a provider of innovative and proprietary nutritional supplements for health-conscious consumers marketed under the brand names NDS Nutrition, PMD, SirenLabs, Nutrology, CoreActive, Metis Nutrition, iSatori, Energize, and BioGenetic Laboratories, today announced preliminary financial results for its fiscal year ended December 31, 2021. The Company is providing the following preliminary financial report, not subject to any procedures by our independent registered accounting firm, regarding its performance for the fiscal year ended December 31, 2021:Total revenue is anticipated to be $27.7-27.9 million. Gross profit is anticipated to be $12.3-12.5...

Q4 Recurring Revenue from Royalties and Interest of $ 1,605,980; YTD $6,091,103 — YoY growth of 13.4% TORONTO, Ontario, April 01, 2022 (GLOBE NEWSWIRE) — Flow Capital Corp. (TSXV: FW) (“Flow Capital”) announces its unaudited financial and operating results for the three-months (“Q4 2021) and year ended December 31, 2021 (“YE 2021”). The release dated March 31, 2022 contained the following clerical errors. The comparative numbers reported for net income (loss) in Q4 2020 and the realized gains in YE 2021 inadvertently referenced the Q3 2021 figures. The corrected release reads as follows: 2021 Performance HighlightsBook value of approximately $0.75 per share; YoY growth of 33.7%. Net income of $ 2,263,807 in Q4 2021, compared to $617,850 in Q4 2020. YTD net income of $5,597,275; YoY growth of 164%. Recurring revenue from...

SAN DIEGO, CA, April 01, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, today announced its financial results for the year ending December 31, 2021, and provided an overview of recent operational highlights. Third Quarter 2021 Financial and Operational HighlightsGenerated $34.1 million in net revenue for fiscal year 2021; Gross profit fiscal year 2021, was $26.9 million representing a gross profit margin of 78%; Total cash balance at year end was $5.4 million; Medical Marijuana, Inc. experienced substantial growth in its international business segments including the establishment of operations in South Africa...